ResearcherGerman Cancer Research CenterActive in the last 2 years
Simon Schallenberg
Matched on ORCID iD 0000-0002-7897-7116; OpenAlex author ID A5054151444. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/2056-4538.70083↗
- DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites. Co-author DOI 10.1186/s13148-024-01768-x↗
- The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/ijms24032160↗
- Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14010201↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mihnea Paul Dragomir · 4 shared papers, 2021–2026 · strength 0.74
- Paper Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. DOI 10.1002/2056-4538.70083↗
- Paper The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms24032160↗
- Paper DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites. DOI 10.1186/s13148-024-01768-x↗
- Florian Nino Loch · 3 shared papers, 2021–2026 · strength 0.58
- Paper Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. DOI 10.1002/2056-4538.70083↗
- Paper The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms24032160↗
- Paper Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14010201↗
- Katharina Beyer · 2 shared papers, 2021–2023 · strength 0.30
- Carsten Kamphues · 2 shared papers, 2021–2023 · strength 0.30
- Frederick Klauschen · 1 shared paper, 2026 · strength 0.28
- Deema Sabtan · 1 shared paper, 2026 · strength 0.28
- Marcus Bahra · 1 shared paper, 2024 · strength 0.16
- Bruno Valentin Sinn · 1 shared paper, 2024 · strength 0.16
- Teodor G. Calina · 1 shared paper, 2024 · strength 0.16
- Christopher Neumann · 1 shared paper, 2024 · strength 0.16
- Elena Grafenhorst · 1 shared paper, 2024 · strength 0.16
- Uwe Pelzer · 1 shared paper, 2024 · strength 0.16
- George A. Călin · 1 shared paper, 2024 · strength 0.16
- Fiona Speichinger · 1 shared paper, 2021 · strength 0.12
- Ioannis Pozios · 1 shared paper, 2021 · strength 0.12
- Georgios Antonios Margonis · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.